Close

CellRapeutics™ RNA Spin Kit (CART-012CL)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Specific Inquiry

  • Size:
  Add to Cart
  • Product Name
  • CellRapeutics™ RNA Spin Kit
  • Cat. No.
  • CART-012CL
  • General Description
  • 96-well format using suitable vacuum manifolds or suitable centrifuges.

    or fast and efficient purification in a 96-well format
    6 samples can be parallel-processed with high reproducibility in under 70 min
    Integrated wash plate eliminates risk of contamination
    Flexible processing by vacuum or centrifugation
    DNase I treatment removes genomic DNA, leading to high-quality total RNA product CellRapeuticsTM RNA Spin Kit can be used to reproducibly isolate total RNA from cultured cells, tissue, bacteria or yeast. It allows for the simultaneous processing of 96 samples via either centrifugation or vacuum-based protocols that can easily fit onto existing automated systems. The isolated RNA is of a high enough quality and quantity (up to 100 µg) for multiple downstream experiments, including sensitive enzymatic applications like quantitative reverse transcription polymerase chain reaction (QRT-PCR), primer extension, and RNase protection assays. Therefore, the RNAspin Kit is a flexible, high-throughput solution for total RNA isolation.
  • Applications
  • Used to reproducibly (well-to-well, plate-to-plate) isolate total RNA from cultured cells, tissue, bacteria or yeast
    Can also be used in a fully automated flow with vacuum on common laboratory workstations
    Suitable for direct use in downstream applications like Quantitative Reverse Transcriptase- PCR (QRT-PCR), Primer Extension, RNase Protection Assays, Cdna Synthesis and Microarray Analysis
  • Preparation Note
  • Total Time of Preparation: 70 min/4 preps
  • Binding Capacity
  • 100 µg
  • Sample Size [Animal Tissue (Vacuum)]
  • 10 mg tissue-30 mg tissue
  • Sample Size [Animal Tissue (Centrifuge)]
  • 30 mg tissue
  • Sample Size [Cell Culture Vacuum]
  • 2 × 106 cells
  • Sample Size [Cell Culture Centrifuge]
  • 1 × 107 cells
  • Typical Yield [Animal Tissue Vacuum]
  • Up to 40 µg
  • Typical Yield [Animal Tissue Centrifuge]
  • Up to 100 µg
  • Typical Yield [Cell Culture Vacuum]
  • Up to 20 µg
  • Typical Yield [Cell Culture Centrifuge]
  • Up to 100 µg
  • RNA Purity [A260/A280]
  • 1.8-2.2
  • Product Size
  • Elution Volume Min.: 50 µl Elution Volume Max.: 130 µl

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ RNA Spin Kit (CART-012CL). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.